← Leaderboards
Austin E Gillen
Va Eastern Colorado Health Care System
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2021–25$1$1$1$0$0
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va Eastern Colorado Health Care System
Same institution · by research overlap
- Wendy M Kohrt$43,514,108
- Jennifer E. Stevens-Lapsley$18,251,552
- David B. Bekelman$2,128,808
- Roman Ayele$0
- Sarah J Wherry$0
Others in their field
Other Emerging Leaders on “Drug Resistance”
- John Damon Chodera · Sloan-Kettering Inst Can Research$58,448,823
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Bruce Blough · Research Triangle Institute$19,637,160
Research focus
Drug ResistanceDisease ResistanceDisease ProgressionAcute Myelocytic LeukemiaAgingAftercareAffectAlternative SplicingAml/MdsAnimal ModelAwardBig DataBiological MarkersBloodCancer CellCancer PatientCell Culture TechniquesCellsCellular AssayClinically RelevantClinical ManagementData AnalysesData ResourceDrug Sensitivity
Grant awards (5)
Cellular Heterogeneity and Aging in MDS and AML$0
IK2 · FY2025 · VA · contact PI
Cellular Heterogeneity and Aging in MDS and AML$0
IK2 · FY2024 · VA · contact PI
Cellular Heterogeneity and Aging in MDS and AML$0
IK2 · FY2023 · VA · contact PI
Cellular Heterogeneity and Aging in MDS and AML$0
IK2 · FY2022 · VA · contact PI
Cellular Heterogeneity and Aging in MDS and AML$0
IK2 · FY2021 · VA · contact PI